Yaz Side Effect Lawsuit Filed by Gilman Law LLP on Behalf of Woman Who Underwent Leg Amputation Following Deep Vein Thrombosis A
NAPLES, Fla. , August 06 /Businesswire/ - Gilman Law LLP has filed a Yaz side effect lawsuit on behalf of young woman who had her right leg amputated in September 2011, after she suffered a serious type of blood clot known as deep vein thrombosis, allegedly due to her use of the Yaz birth control pill. The lawsuit, which was filed on May 24, 2012, in the U.S. District Court, Southern District of Illinois, alleges that the Plaintiff’s injuries were caused by the wrongful acts, omissions, and fraudulent misrepresentations of Bayer and other Defendants. (Case No. 3:12-cv-10862-DRH-PMF)
Gilman Law LLP is offering free Yaz and Yasmin lawsuit evaluations to young women who suffered serious, life-threatening side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes, or gall bladder disease, while using one of these contraceptives. Roughly 10,000 Yaz and Yasmin lawsuits are pending in the Yaz and Yasmin (Drosperinone) Marketing, Sales Practices, and Relevant Products Liability Litigation (MDL 2100) now underway in the Southern District of Illinois. According to a recent report from the Madison Record, some 1,500 complaints have been resolved, and it is expected that settlements in nearly all cases will occur within the year. Victims of Yaz and Yasmin injuries are urged to contact Gilman Law LLP to ensure their legal rights are protected. Once the litigation in the Southern District of Illinois concludes, there will be no further opportunity for recovering compensation from Bayer and other Defendants. [http://www.madisonrecord.com/news/245130-settlements-in-yaz-litigation-continue-mediator-is-cautiously-optimistic-that-end-is-in-sight]
According to the Yaz lawsuit filed by Gilman Law LLP, Yaz and Yasmin are different from other combined hormonal birth control pills in that they contain drospirenone, a fourth-generation progestin. Among other things, drospirenone is associated with hyperkalemia, a condition that occurs when potassium levels in the body become too high. Hyperkalemia can disrupt normal heart rhythms, potentially leading to blood clots. In April 2012, the U.S. Food & Drug Administration (FDA) ordered stronger warning labels for drospirenone birth control pills, following the publication of studies that found the drugs were more likely to cause blood clots compared to contraceptives made with other forms of progestin. [www.fda.gov/Drugs/DrugSafety/ucm273021.htm]
The complaint alleges that had the Defendants properly disclosed risks associated with Yaz, the Plaintiff would not have used it and would not have suffered the serious and permanent injuries described in the lawsuit. Among other things, the lawsuit points out that the Defendants were warned by the FDA in 2003, 2008 and 2009 for misleading the public through the use of ads which overstated the efficacy of Yaz and minimized serious risks associated with the drug. The Defendants ultimately agreed to spend at least $20 million on corrective TV advertisements and to submit all Yaz advertisements to the FDA for advanced screening for six years, according to the complaint.
Time is running out for victims of Yaz and Yasmin to file claims in the federal litigation now underway in the Southern District of Illinois. Young woman injured by Yaz and Yasmin must seek legal counsel now to ensure they are fairly compensated for their injuries. For a free Yaz or Yasmin lawsuit consultation, please contact Gilman Law LLP today by visiting Gilmanlawllp.com, or call Toll Free at 1-888-252-0048.
About Gilman Law LLP
Gilman Law LLP, a leading national law firm with offices in Florida and Massachusetts, has been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits. For over 32 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.